|
From
•>>August 2003
Keiichi Hiramatsu answers
a few questions about this month's emerging research front
in
field of Microbiology: Microbiology
Article: "Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus"
Author: Ito, T;Katayama, Y;Asada, K;Mori, N;Tsutsumimoto, K;Tiensasitorn,
C;Hiramatsu, K
Journal: ANTIMICROB AGENTS CHEMOTHER, 45: (5) 1323-1336, MAY 2001
Addresses:
Juntendo Univ, Dept Bacteriol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.
Juntendo Univ, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan.
|
|
Why
do you think your paper is highly cited?
|

|
|
Our paper is about the world's most notorious hospital pathogen methicillin-resistant Staphylococcus aureus (MRSA) to which even our best antibiotics, penicillins and cephalosporins, are ineffective.
|
|
Our paper is about the world's most notorious hospital pathogen,
methicillin-resistant Staphylococcus aureus (MRSA) to which
even our best antibiotics, penicillins and cephalosporins, are
ineffective. S. aureus is usually a benign member of
our normal flora, but it is transformed into MRSA when a unique
mobile genetic element called staphylococcus cassette chromosome mec
(SCCmec) is integrated into the chromosome. We named it as
such because it is a considerably big element of 20~60 kilobases and
precisely integrated to and excised from the fixed site of S.
aureus chromosome. The paper demonstrated that there are at
least three molecular types in SCCmec, and thus there are at
least three distinct MRSA clones in the world. Now the SCCmec
typing has become an important tool in the field of world-wide
molecular epidemiology of MRSA strains. I think this is the reason
why the paper is highly cited recently.
Does
it describe a new discovery or new methodology that's useful to
others?
The paper showed unequivocally that there are multiple clones of
MRSA in the world by describing that either one of the three
distinct SCCmec elements is integrated in each MRSA strain.
This also opened up a new methodology for molecular typing of MRSA
in the world.
How
did you become involved in this research?
I started my study on MRSA in 1989. At that time the methicillin-resistance
gene, mecA, had been cloned by Matsuhashi's group in Tokyo
University. The gene mecA was not found in methicillin-susceptible S.
aureus. Therefore, it was suspected that mecA was acquired from
other bacterial species by lateral gene transfer. I wanted to know
how the mecA gene came into S. aureus chromosome. So I and my
colleague Teruyo Ito started cloning and sequencing of the
chromosome regions around mecA gene using a Japanese MRSA strain. We
completed sequencing and realized that the mecA gene was carried by
a novel genetic element distinct from any of the previous families
of mobile genetic elements such as transposons, bacteriophages,
conjugative plasmids, etc. Subsequent genetic experiments
demonstrated the movement of the element, and we designated it SCCmec.
Then, by analyzing the MRSA strains of 20 countries, we realized
that the type of SCCmec (now type-II is assigned for this
type) was detectable only in Japanese and certain American MRSA
strains. We therefore started to clone and sequence all of these
non-type-II SCCmec. Old British MRSA strains had a distinct
type of SCCmec (type-I), and another group of strains
distributed widely in England, Europe, and South East Asian
countries (we call it "British Empire Strain" ) had
another type of SCCmec (type-III). The three types covered
more than 90% of the MRSA strains from 20 countries. We submitted
the results to AAC which is the one discussed here.
Keiichi Hiramatsu
Department of Microbiology and Infection Control Science
Juntendo University
Tokyo, Japan
|
Return to Emerging Research Fronts | Return
to Special Topics main menu
|